e497-abfunds.htm - Generated by SEC Publisher for SEC Filing

0001133228-18-006113.txt : 20181102 0001133228-18-006113.hdr.sgml : 20181102 20181102172225 ACCESSION NUMBER: 0001133228-18-006113 CONFORMED SUBMISSION TYPE: 497 PUBLIC DOCUMENT COUNT: 13 FILED AS OF DATE: 20181102 DATE AS OF CHANGE: 20181102 EFFECTIVENESS DATE: 20181102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN BEACON FUNDS CENTRAL INDEX KEY: 0000809593 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: 497 SEC ACT: 1933 Act SEC FILE NUMBER: 033-11387 FILM NUMBER: 181158124 BUSINESS ADDRESS: STREET 1: 220 EAST LAS COLINAS BOULEVARD STREET 2: SUITE 1200 CITY: IRVING STATE: TX ZIP: 75039 BUSINESS PHONE: 8173916100 MAIL ADDRESS: STREET 1: 220 EAST LAS COLINAS BOULEVARD STREET 2: SUITE 1200 CITY: IRVING STATE: TX ZIP: 75039 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN AADVANTAGE FUNDS DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN EAGLE FUNDS DATE OF NAME CHANGE: 19890813

0000809593 S000056147 American Beacon ARK Transformational Innovation Fund

C000176824 Institutional Class ADNIX

C000176825 Investor Class ADNPX

C000176826 Y Class ADNYX

497 1 e497-abfunds.htm AMERICAN BEACON ARK TRANSFORMATIONAL INNOVATION FUND - 497 XBRL e497-abfunds.htm - Generated by SEC Publisher for SEC Filing

American Beacon Advisors, Inc.

220 E. Las Colinas Blvd., Ste. 1200

Irving, TX 75039

November 2, 2018

VIA EDGAR

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Re:	American Beacon Funds 1933 Act File No. 33-11387 1940 Act File No. 811-4984

Dear Sir or Madam:

Enclosed for filing, pursuant to Rule 497(c) of the Securities Act of 1933, as amended, are exhibits containing risk/return summary information in interactive data format for the shares of beneficial interest in the American Beacon ARK Transformational Innovation Fund (the “Fund”), a series of the American Beacon Funds. The exhibits reflect updated risk/return summary information for the Fund, as filed with the Securities and Exchange Commission pursuant to Rule 497(c) on October 25, 2018 (Accession Number: 0001133228-18-006022), which is incorporated herein by reference.

If you have any questions concerning the foregoing, please do not hesitate to contact the undersigned at (817) 391-6170.

Sincerely,

/s/ Rosemary Behan

Rosemary Behan
Chief Legal Officer

cc: Kathy K. Ingber, Esq.

K&L Gates LLP

EX-101.INS 2 abfunds-20181025.xml XBRL INSTANCE DOCUMENT 0000809593 2018-10-25 2018-10-25 0000809593 abfunds-20181025:S000056147Member 2018-10-25 2018-10-25 0000809593 abfunds-20181025:S000056147Member abfunds-20181025:C000176826Member 2018-10-25 2018-10-25 0000809593 abfunds-20181025:S000056147Member abfunds-20181025:C000176824Member 2018-10-25 2018-10-25 0000809593 abfunds-20181025:S000056147Member abfunds-20181025:C000176825Member 2018-10-25 2018-10-25 xbrli:pure iso4217:USD xbrli:shares iso4217:USD xbrli:shares 497 2018-06-30 AMERICAN BEACON FUNDS 0000809593 false 2018-10-28 2018-10-25 2018-10-25 Investment Objective The Fund seeks long-term growth of capital. Fees and Expenses of the Fund This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund. More information is available from your financial professional and in "Choosing Your Share Class" on page 16 of the Prospectus. Shareholder Fees (fees paid directly from your investment) Annual Fund Operating Expenses (Expenses that you pay each year as a percentage of the value of your investment) Example This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same, except that the Example reflects the fee waiver/expense reimbursement arrangement for each share class through October 28, 2019, and the tax liability reimbursement arrangement. Although your actual costs may be higher or lower, based on these assumptions, your costs would be: Portfolio Turnover The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual Fund operating expenses or in the Example, affect the Fund's performance. During the most recent fiscal year, the Fund's portfolio turnover rate was 59% of the average value of its portfolio. Principal Investment Strategies The Fund seeks to achieve long-term growth of capital by investing primarily in domestic and foreign equity securities of transformational innovation companies. The sub-advisor defines transformational innovation companies as those with divisions that primarily focus on developing or benefitting from new products, services, technologies or advancements that disrupt, or are expected to disrupt, existing markets or processes. The types of transformational innovation companies that the Fund expects to invest in are those companies primarily engaged in research, including research relating to: (i) genomics ("Genomic Revolution Research"), (ii) industrial innovation ("Industrial Innovation Research"), (iii) shared technology and the internet ("Next Generation Internet Research"), or (iv) financial services ("FinTech Innovation Research"), among others. The sub-advisor uses internally-generated and externally-sourced research and analysis to assemble a diverse array of information from which to identify transformational innovation companies. <ul><li> Genomic Revolution Research. The sub-advisor defines Genomic Revolution Research as research that focuses on extending and enhancing the quality of human, and other, life. This research incorporates technological and scientific developments, improvements and advancements in genomics (the study of genes, DNA and their functions, and related analytical techniques), bionics and products or services that improve and enhance life and fundamentally change existing industries. Genomic Sequencing refers to the techniques that allow researchers to read and decipher the genetic information found in DNA. Genomic Revolution Research may be classified in multiple sectors including health care, information technology, materials, energy and consumer discretionary. </li><li> Industrial Innovation Research. The sub-advisor defines Industrial Innovation Research as research that focuses on technological improvements and advancements in the industrial sectors, including energy, manufacturing, and transportation. For example, energy transformation companies may seek to develop innovations in areas of energy location, development, storage or usage. Transportation companies may seek to develop innovation in the areas of mobility, such as drones and self-driving cars. Manufacturing innovators may seek applications for robotics, 3D printing, and similar productivity-enhancing technologies. </li><li> Next Generation Internet Research. The sub-advisor defines Next Generation Internet Research as research that focuses on developments in the global technology infrastructure, including hardware, software and the shift to mobile devices. This research may incorporate shared technology, such as shared data storage and processing, computer network applications and internet security. Applications could include, those that link homes, automobiles and workplaces to mobile devices or other convenient media. </li><li> FinTech Innovation Research. The sub-advisor defines FinTech Innovation Research as that research that focuses on innovations in the financial sector including payment technologies, lending methods, currencies and business analytics. Technology-enabled enhancements in financial services may also interact with a variety of other innovation themes as the concepts of finance apply across industries and transactions. </li></ul> The sub-advisor's process for identifying investments uses both ''top down'' (macro-economic and business cycle analysis) and ''bottom up'' (valuation, fundamental and quantitative measures) approaches to identify investment opportunities. Under normal circumstances, substantially all of the Fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the Fund's investment theme of transformational innovation. The Fund's investments include issuers of all capitalizations. The Fund's investments in foreign equity securities are in both developed and emerging markets. The Fund invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The Fund may engage in foreign currency transactions either on a spot (cash) basis at the rate prevailing in the currency exchange market or through forward currency contracts ("forwards"). The Fund also may use foreign currency forward contracts to hedge exposure to foreign currency or to shift exposure from one currency to another. The Fund may have significant exposure to the Health Care and Information Technology sectors. However, as the sector composition of the Fund's portfolio changes over time, the Fund's exposure to these sectors may be lower at a future date, and the Fund's exposure to other market sectors may be higher. The sub-advisor may sell a security if it believes that a company has become disrupted or is no longer on the leading edge of fast-moving industries or innovation. The sub-advisor may also sell positions to (i) take advantage of opportunities created by short-term market actions or market sentiment, (ii) provide liquidity to invest in companies that the sub-advisor has relatively more confidence in, or (iii) invest in companies that the sub-advisor believes offer more market opportunity relative to their current price. The Fund at times may invest in shares of other investment companies, including money market funds and exchange-traded funds ("ETFs"), and may lend its securities to broker-dealers and other institutions to earn additional income. The Fund may invest in securities of investment companies advised by the Manager. In pursuing its investment strategies, the Fund typically engages in active trading strategies that result in high portfolio turnover. The Fund is non-diversified, which means that it may invest a high percentage of its assets in a limited number of issuers. The Fund is the sole shareholder of a wholly owned subsidiary that is organized under the laws of the Cayman Islands (the "Subsidiary"). The Subsidiary was established to enable the Fund to seek exposure to certain investments that may not produce qualifying income for the Fund under the Internal Revenue Code of 1986, as amended. The Subsidary has not engaged in any investment activity and is not expected to do so in the future. The Subsidiary is anticipated to terminate in the near future. Principal Risks There is no assurance that the Fund will achieve its investment objective and you could lose part or all of your investment in the Fund. The Fund is not designed for investors who need an assured level of income and is intended to be a long-term investment. The Fund is not a complete investment program and may not be appropriate for all investors. Investors should carefully consider their own investment goals and risk tolerance before investing in the Fund. The principal risks of investing in the Fund are: Allocation and Correlation Risk The sub-advisor's judgments about, and allocations among asset classes and market exposures may adversely affect the Fund's performance. There can be no assurance, particularly during periods of market disruption and stress, that the sub-advisor's judgements about asset allocation and market correlations will be correct. Asset Selection Risk Assets selected by the sub-advisor or the Manager for the Fund may not perform to expectations. The sub-advisor's investment models may rely in part on data derived from third parties and may not perform as intended. This could result in the Fund's underperformance compared to other funds with similar investment objectives. Currency Risk The Fund may have exposure to foreign currencies by making direct investments in non-U.S. currencies, investing in securities denominated in non-U.S. currencies or by purchasing or selling forward currency exchange contracts in non-U.S. currencies. Foreign currencies will fluctuate, and may decline in value relative to the U.S. dollar and other currencies and thereby affect the Fund's investments in foreign (non-U.S.) currencies or in securities that trade in, and receive revenues in, or in derivatives that provide exposure to, foreign (non-U.S.) currencies. Cybersecurity and Operational Risk The Fund and its service providers, and shareholders' ability to transact with the Fund, may be negatively impacted due to operational risks arising from, among other problems, human errors, systems and technology disruptions or failures, or cybersecurity incidents. Cybersecurity incidents may allow an unauthorized party to gain access to Fund assets, customer data, or proprietary information, or cause the Fund or its service providers, as well as the securities trading venues and their service providers, to suffer data corruption or lose operational functionality. It is not possible for the Fund or its service providers to identify all of the operational risks that may affect the Fund or to develop processes and controls to completely eliminate or mitigate their occurrence or effects. Most issuers in which the Fund invests are heavily dependent on computers for data storage and operations, and require ready access to the internet to conduct their business. Thus, cybersecurity incidents could also affect issuers of securities in which the Fund invests, leading to significant loss of value. Derivatives Risk Derivatives may involve significant risk. The use of derivative instruments may expose the Fund to additional risks that it would not be subject to if it invested directly in the securities or other instruments underlying those derivatives, including the high degree of leverage often embedded in such instruments, and potential material and prolonged deviations between the theoretical value and realizable value of a derivative. Some derivatives have the potential for unlimited loss, regardless of the size of the Fund's initial investment. Derivatives may be illiquid and may be more volatile than other types of investments. The Fund may buy or sell derivatives not traded on an exchange and which may be subject to heightened liquidity and valuation risk. Derivative investments can increase portfolio turnover and transaction costs. Derivatives also are subject to counterparty risk and credit risk. As a result, the Fund may obtain no recovery of its investment or may only obtain a limited recovery, and any recovery may be delayed. Not all derivative transactions require a counterparty to post collateral, which may expose the Fund to greater losses in the event of a default by a counterparty. Ongoing changes to regulation of the derivatives market and potential changes in the regulation of funds using derivative instruments could limit the Fund's ability to pursue its investment strategies.In addition, the Fund's investments in derivatives are subject to the following risks: <ul><li> Forward Contracts. Forward contracts are derivative instruments pursuant to a contract where one party pays a fixed price for an agreed amount of securities or other underlying assets at an agreed date or to buy or sell a specific currency at a future date at a price set at the time of the contract. There can be no assurance that any strategy used will succeed. Not all forward contracts require a counterparty to post collateral, which may expose the Fund to greater losses in the event of a default by a counterparty. Forward currency transactions and forward currency contracts include the risks associated with fluctuations in currency. </li></ul> Emerging Markets Risk When investing in emerging markets, the risks of investing in foreign securities discussed below are heightened. Emerging markets are generally smaller, less developed, less liquid and more volatile than the securities markets of the U.S. and other developed markets. There are also risks of: greater political uncertainties; an economy's dependence on revenues from particular commodities or on international aid or development assistance; currency transfer restrictions; a limited number of potential buyers for such securities resulting in increased volatility and limited liquidity for emerging market securities; trading suspensions; and delays and disruptions in securities settlement procedures. Equity Investments Risk Equity securities are subject to investment risk and market risk. The Fund's investments in U.S. and foreign equity securities may include common stocks and depositary receipts. Such investments may expose the Fund to additional risks. <ul><li> Common Stock. The value of a company's common stock may fall as a result of factors affecting the company, companies in the same industry or sector, or the financial markets overall. Common stock generally is subordinate to preferred stock upon the liquidation or bankruptcy of the issuing company. </li><li> Depositary Receipts. Depositary receipts and U.S. dollar-denominated foreign stocks traded on U.S. exchanges are subject to certain of the risks associated with investing directly in foreign securities including, but not limited to, currency exchange rate fluctuations, political and financial instability in the home country of a particular depositary receipt or foreign stock, less liquidity and more volatility, less government regulation and supervision and delays in transaction settlement. </li></ul> Foreign Investing Risk Non-U.S. investments carry potential risks not associated with U.S. investments. Such risks include, but are not limited to: (1) currency exchange rate fluctuations, (2) political and financial instability, (3) less liquidity, (4) lack of uniform accounting, auditing and financial reporting standards, (5) increased volatility, (6) different government regulation and supervision of foreign stock exchanges, brokers and listed companies, and (7) delays in transaction settlement in some foreign markets. Hedging Risk If the Fund uses a hedging instrument at the wrong time or judges the market conditions incorrectly, or the hedged instrument does not correlate to the risk sought to be hedged, the hedge might be unsuccessful, reduce the Fund's return, or create a loss. In addition, hedges, even when successful in mitigating risk, may not prevent the Fund from experiencing losses on its investments, and therefore the use of hedging strategies may reduce the Fund's return, or create a loss. Investment Risk An investment in the Fund is not a deposit with a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. When you sell your shares of the Fund, they could be worth less than what you paid for them. Therefore, you may lose money by investing in the Fund. Issuer Risk The value of, and/or the return generated by, a security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage and reduced demand for the issuer's goods or services, as well as the historical and prospective earnings of the issuer and the value of its assets. Large Capitalization Companies Risk The securities of large market capitalization companies may underperform other segments of the market because such companies may be less responsive to competitive challenges and opportunities and may be unable to attain the high growth rates of successful smaller companies, especially during periods of economic expansion. Liquidity Risk The Fund is susceptible to the risk that certain investments held by the Fund, such as forward contracts, may have limited marketability or be subject to restrictions on sale, and may be difficult or impossible to purchase or sell at favorable times or prices. The Fund could lose money if it is unable to dispose of an investment at a time that is most beneficial to the Fund. The Fund may be required to dispose of investments at unfavorable times or prices to satisfy obligations, which may result in losses or may be costly to the Fund. For example, the Fund may be forced to sell certain investments at unfavorable prices to meet redemption requests or other cash needs. Judgment plays a greater role in pricing illiquid investments than in investments with more active markets. Market Risk Since the financial crisis that started in 2008, the U.S. and many foreign economies continue to experience its after-effects, which have resulted, and may continue to result, in fixed income instruments experiencing unusual liquidity issues, increased price volatility and, in some cases, credit downgrades and increased likelihood of default. These events have reduced the willingness and ability of some lenders to extend credit, and have made it more difficult for some borrowers to obtain financing on attractive terms, if at all. In addition, global economies and financial markets are becoming increasingly interconnected, which increases the possibilities that conditions in one country or region might adversely impact issuers in a different country or region. A rise in protectionist trade policies, and the possibility of changes to some international trade agreements, could affect the economies of many nations in ways that cannot necessarily be foreseen at the present time. The severity or duration of adverse economic conditions may also be affected by policy changes made by governments or quasi-governmental organizations. In addition, political events within the U.S. and abroad may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. High public debt in the U.S. and other countries creates ongoing systemic and market risks and policymaking uncertainty. Because the impact on the markets has been widespread, it may be difficult to identify both risks and opportunities using past models of the interplay of market forces, or to predict the duration of these market conditions. Interest rates have been unusually low in recent years in the U.S. and abroad. Because there is little precedent for this situation, it is difficult to predict the impact on various markets of a significant rate increase, whether brought about by U.S. policy makers or by dislocations in world markets. In addition, there is a risk that the prices of goods and services in the U.S. and many foreign economies may decline over time, known as deflation (the opposite of inflation). Deflation may have an adverse effect on stock prices and creditworthiness and may make defaults on debt more likely. Market Timing Risk Because the Fund invests in foreign securities, or it has exposure to foreign securities through the derivatives it holds, it is particularly subject to the risk of market timing activities. Frequent trading by Fund shareholders poses risks to other shareholders in the Fund, including (i) the dilution of the Fund's net asset value ("NAV"), (ii) an increase in the Fund's expenses, and (iii) interference with the portfolio manager's ability to execute efficient investment strategies. Because of specific types of securities in which the Fund may invest, it could be subject to the risk of market timing activities by shareholders. Micro-Capitalization Companies Risk Micro-capitalization companies are subject to substantially greater risks of loss and price fluctuations because their earnings and revenues tend to be less predictable, since micro-capitalization companies may not have operating history, product lines, and financial resources. Their share prices tend to be more volatile and their markets less liquid than companies with larger market capitalizations, and they can be sensitive to expected changes in interest rates, borrowing costs and earnings. The shares of micro-capitalization companies tend to trade less frequently than those of larger, more established companies, which can adversely affect the pricing of these securities and the future ability to sell these securities. Model Risk The sub-advisor may use proprietary modeling systems to implement its investment strategies for the Fund. Investments selected using these models may perform differently than expected as a result of the factors used in the models, the weight placed on each factor, changes from the factors' historical trends and technical issues in the construction and implementation of the models. There is no assurance that the models are complete or accurate, or representative of future market cycles, nor will they necessarily be beneficial to the Fund if they are accurate. These models may negatively affect Fund performance for various reasons, including human judgment, inaccuracy of historical data and non-quantitative factors (such as market or trading system dysfunctions, investor fear or over-reaction). Non-Diversification Risk The Fund is non-diversified, which means it may focus its investments in the securities of a comparatively small number of issuers. Investments in securities of a limited number of issuers exposes the Fund to greater market risk and potential losses than if assets were diversified among the securities of a greater number of issuers. Other Investment Companies Risk The Fund may invest in shares of other registered investment companies, including money market funds and exchange-traded funds ("ETFs"). To the extent that the Fund invests in shares of other registered investment companies, the Fund will indirectly bear the fees and expenses charged by those investment companies in addition to the Fund's direct fees and expenses and will be subject to the risks associated with investments in those companies. For example, money market funds are subject to interest rate risk, credit risk, and market risk. To the extent the Fund invests in ETFs that invest in equity securities, fixed income securities and/or foreign securities, or that track an index, the Fund would be subject to the risks associated with the underlying investments held by the ETF or the index fluctuations to which the ETF is subject. Because ETFs are listed on an exchange, they may be subject to trading halts, may trade at a discount or premium to their NAV and may not be liquid. ETF shares may trade at a premium or discount to their NAV. An ETF that tracks an index may not precisely replicate the returns of its benchmark index. Sector Risk To the extent the Fund invests more heavily in particular sectors, its performance will be especially sensitive to developments and economic conditions that significantly affect those sectors. Individual sectors may move up and down more than the broader market. The industries that constitute a sector may all react in the same way to economic, political or regulatory events. Because the Fund may hold a limited number of securities, it may at times be substantially over-weighted in certain economic sectors and under-weighted in others. Accordingly, the Fund's performance is likely to be disproportionately affected by the factors influencing those sectors. <ul><li> Health Care Sector Risk. The health care sector may be affected by government regulations and health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Many health care companies are (i) heavily dependent on patent protection and intellectual property rights and the expiration of a patent may adversely affect their profitability, (ii) subject to extensive litigation based on product liability and similar claims, and (iii) subject to competitive forces that may make it difficult to raise prices and, may result in price discounting. Many health care products and services may be subject to regulatory approvals. The process of obtaining such approvals may be long and costly, and delays in or failure to receive such approvals may negatively impact the business of such companies. Additional or more stringent laws and regulations enacted in the future could have a material adverse effect on companies in the health care sector. In addition, issuers in the health care sector include issuers having their principal activities in the biotechnology and pharmaceutical industries, which have the additional risks described below. </li> </ul> <ul style="padding-left:60px"> <li> Biotechnology Company Risk. A biotechnology company's valuation can often be based largely on the potential or actual performance of a limited number of products and can accordingly be greatly affected if one of its products proves unsafe, ineffective or unprofitable. </li><li> Pharmaceutical Company Risk. Companies in the pharmaceutical industry can be significantly affected by government approval of products and services, government regulation and reimbursement rates, product liability claims, patent expirations and intense competition. </li></ul> <ul><li> Information Technology Sector Risk. The information technology sector includes companies engaged in internet software and services, technology hardware and storage peripherals, electronic equipment and components, and semiconductors and semiconductor equipment. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Information technology companies may have limited product lines, markets, financial resources or personnel. The products of information technology companies may face rapid product obsolescence due to technological developments and frequent new product introduction, unpredictable changes in growth rates and competition for the services of qualified personnel. Failure to introduce new products, develop and maintain a loyal customer base or achieve general market acceptance for their products could have a material adverse effect on a company's business. Companies in the information technology sector are heavily dependent on intellectual property and the loss of patent, copyright and trademark protections may adversely affect the profitability of these companies. </li> </ul> <ul style="padding-left:60px"> <li> Financial Technology Company Risk. FinTech companies generally face competition from much larger and more established firms. FinTech companies may not be able to capitalize on their disruptive technologies if they face political and/or legal attacks from competitors, industry groups or local and national governments. A FinTech company may not currently or in the future derive any revenue from innovative technologies. </li></ul> Securities Lending Risk To the extent the Fund lends its securities, it may be subject to the following risks: i) borrowers of the Fund's securities typically provide collateral in the form of cash that is reinvested in securities, ii) the securities in which the collateral is invested may not perform sufficiently to cover the return collateral payments owed to borrowers, iii) delays may occur in the recovery of securities from borrowers, which could interfere with the Fund's ability to vote proxies or to settle transactions, and iv) there is the risk of possible loss of rights in the collateral should the borrower fail financially. Small and Mid-Capitalization Companies Risk Investing in the securities of small and mid-capitalization companies involves greater risk and the possibility of greater price volatility than investing in larger capitalization and more established companies. Since small and mid-capitalization companies may have narrower commercial markets and more limited operating history, product lines, and managerial and financial resources than larger, more established companies, the securities of these companies may lack sufficient market liquidity, and they can be particularly sensitive to expected changes in interest rates, borrowing costs and earnings. In general, these risks are greater for small-capitalization companies than for mid-capitalization companies. Transformational Innovation Risk Companies that the sub-advisor believes are capitalizing on transformational innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. Companies that develop transformational technologies may face political or legal challenges from competitors, industry groups or local and national governments. These companies may also be exposed to risks applicable to sectors other than the transformational innovation theme for which they are chosen, and the securities issued by these companies may underperform the securities of other companies that are also focused on a particular theme. Valuation Risk The Fund may value certain assets at a price different from the price at which they can be sold. This risk may be especially pronounced for investments that are illiquid or which may become illiquid. Fund Performance Performance information for the Fund is not provided because the Fund had not been in operation for a full calendar year as of the date of this Prospectus. Performance for the Fund can be accessed on the Fund's website at www.americanbeaconfunds.com. Past performance (before and after taxes) is not necessarily an indication of how the Fund will perform in the future. <div style="display:none">~http://abfunds-20181025/role/ShareholderFeesDataBBBB column period compact * column rr_ProspectusShareClassAxis compact * row primary compact * row dei_LegalEntityAxis compact abfunds-20181025_S000056147Member ~</div> 0 0 0 0 0 0 <div style="display:none">~ http://abfunds-20181025/role/OperatingExpensesDataBBBB column period compact * column rr_ProspectusShareClassAxis compact * row primary compact * row dei_LegalEntityAxis compact abfunds-20181025_S000056147Member ~</div> 0.009 0.0394 0.0067 0.0327 0.0001 0.0485 -0.0308 0.0067 0.011 0.009 0.0384 0.0067 0.0317 0.0001 0.0475 -0.0308 0.0067 0.01 0.009 0.0406 0.0067 0.0339 0.0001 0.0497 -0.0292 0.0067 0.0138 <div style="display:none">~ http://abfunds-20181025/role/ExpenseExampleBBBB column period compact * column rr_ProspectusShareClassAxis compact * row primary compact * row dei_LegalEntityAxis compact abfunds-20181025_S000056147Member ~</div> 112 102 141 1121 1092 1171 2134 2088 2202 4678 4598 4782 October 28, 2019 0.59 The Total Annual Fund Operating Expenses do not correlate to the ratio of expenses to average net assets provided in the Fund's Financial Highlights table, which reflects the operating expenses of the Fund and does not include Acquired Fund Fees and Expenses. An investment in the Fund is not a deposit with a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. There is no assurance that the Fund will achieve its investment objective and you could lose part or all of your investment in the Fund. Non-Diversification Risk The Fund is non-diversified, which means it may focus its investments in the securities of a comparatively small number of issuers. Investments in securities of a limited number of issuers exposes the Fund to greater market risk and potential losses than if assets were diversified among the securities of a greater number of issuers. Past performance (before and after taxes) is not necessarily an indication of how the Fund will perform in the future. www.americanbeaconfunds.com The Total Annual Fund Operating Expenses do not correlate to the ratio of expenses to average net assets provided in the Fund's Financial Highlights table, which reflects the operating expenses of the Fund and does not include Acquired Fund Fees and Expenses. The Manager has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust through October 28, 2019. The contractual agreement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees. During the last fiscal year, the Fund invested in a wholly owned subsidiary organized under Delaware law (the "Delaware Subsidiary"). The Delaware Subsidiary's financial statements are consolidated with those of the Fund. The Delaware Subsidiary, which was liquidated on October 25, 2018, was classified for federal tax purposes as a regular corporation or so-called "C" corporation. As a "C" corporation, the Delaware Subsidiary incurred federal income tax liability associated with gains that the Delaware Subsidiary recognized on sales of its sole investment, shares of the Bitcoin Investment Trust, which the Fund had contributed to the Delaware Subsidiary. As described in Footnote 4 below, American Beacon Advisors, Inc. (the "Manager") has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust. Therefore, the reduction in the Delaware Subsidiary's value resulting from that liability did not adversely impact the Fund's net asset value per share. American Beacon Advisors, Inc. (the "Manager") has contractually agreed to waive fees and/or reimburse expenses of the Fund's Y Class, Institutional Class and Investor Class shares through October 28, 2019 to the extent that Total Annual Fund Operating Expenses exceed 1.09% for the Y Class, 0.99% for the Institutional Class and 1.37% for the Investor Class (excluding taxes, interest, brokerage commissions, acquired fund fees and expenses, securities lending fees, expenses associated with securities sold short, litigation, and other extraordinary expenses). The contractual expense reimbursement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees. The Manager can be reimbursed by the Fund for any contractual fee waivers or expense reimbursements if reimbursement to the Manager (a) occurs within three years after the Manager's own waiver or reimbursement and (b) does not cause the Total Annual Fund Operating Expenses of a class to exceed the lesser of the contractual percentage limit in effect at the time of the waiver/reimbursement or the time of the recoupment. EX-101.SCH 3 abfunds-20181025.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 010001 - Document - Document And Entity Information {Elements} link:presentationLink link:calculationLink link:definitionLink 010002 - Document - American Beacon Funds {Unlabeled} link:presentationLink link:calculationLink link:definitionLink 020012 - Schedule - Shareholder Fees link:presentationLink link:calculationLink link:definitionLink 020022 - Schedule - Annual Fund Operating Expenses link:presentationLink link:calculationLink link:definitionLink 020032 - Schedule - Expense Example {Transposed} link:presentationLink link:calculationLink link:definitionLink 010003 - Document - American Beacon ARK Transformational Innovation Fund {Unlabeled} link:presentationLink link:calculationLink link:definitionLink 020013 - Schedule - Shareholder Fees link:presentationLink link:calculationLink link:definitionLink 020023 - Schedule - Annual Fund Operating Expenses link:presentationLink link:calculationLink link:definitionLink 020034 - Schedule - Expense Example {Transposed} link:presentationLink link:calculationLink link:definitionLink 010004 - Document - American Beacon TwentyFour Strategic Income Fund {Unlabeled} link:presentationLink link:calculationLink link:definitionLink 020014 - Schedule - Shareholder Fees link:presentationLink link:calculationLink link:definitionLink 020024 - Schedule - Annual Fund Operating Expenses link:presentationLink link:calculationLink link:definitionLink 020036 - Schedule - Expense Example {Transposed} link:presentationLink link:calculationLink link:definitionLink 020044 - Schedule - Expense Example, No Redemption {Transposed} link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 abfunds-20181025_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 abfunds-20181025_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Expense Example, No Redemption: Shareholder Fees [Table] Annual Fund Operating Expenses [Table] Expense Example, With Redemption [Table] Bar Chart [Table] Performance [Table] Expense Example, No Redemption Narrative [Text Block] Market Index Performance [Table] Expense Example, No Redemption [Table] Performance Measure [Axis] Before Taxes After Taxes on Distributions After Taxes on Distributions and Sales Amendment Description Amendment Flag Document Creation Date Document Effective Date Document [Axis] Prospectus Document Period End Date Document Type Entities [Table] Entity [Text Block] Series Trading Symbol Registrant Name Central Index Key Series [Axis] Risk/Return [Heading] Objective Section: Objective [Heading] Objective, Primary [Text Block] Objective, Secondary [Text Block] Strategy Section: Strategy [Heading] Strategy Narrative [Text Block] Strategy Portfolio Concentration [Text] Bar Chart and Performance Table [Heading] Performance Narrative [Text Block] Performance Past Does Not Indicate Future [Text] Performance Information Illustrates Variability of Returns [Text] Performance One Year or Less [Text] Performance Additional Market Index [Text] Bar Chart [Heading] Bar Chart Narrative [Text Block] Bar Chart Does Not Reflect Sales Loads [Text] Bar Chart, Returns for Class Not Offered in Prospectus [Text] Bar Chart, Reason Selected Class Different from Immediately Preceding Period [Text] Annual Return Caption [Text] Caption Annual Return, Column [Text] Column Annual Return, Inception Date Inception Date Annual Return 1990 Annual Return 1991 Annual Return 1992 Annual Return 1993 Annual Return 1994 Annual Return 1995 Annual Return 1996 Annual Return 1997 Annual Return 1998 Annual Return 1999 Annual Return 2000 Annual Return 2001 Annual Return 2002 Annual Return 2003 Annual Return 2004 Annual Return 2005 Annual Return 2006 Annual Return 2007 Annual Return 2008 Annual Return 2009 Annual Return 2010 Annual Return 2011 Annual Return 2012 Annual Return 2013 Annual Return 2014 Annual Return 2015 Annual Return 2016 Annual Return 2017 Annual Return 2018 Annual Return 2019 Annual Return 2020 Year to Date Return, Label Bar Chart, Year to Date Return Bar Chart, Year to Date Return, Date Highest Quarterly Return, Label Label Highest Quarterly Return Highest Quarterly Return, Date Lowest Quarterly Return, Label Label Lowest Quarterly Return Lowest Quarterly Return, Date Bar Chart Closing [Text Block] Performance Table Heading Performance Table Narrative Performance Table Does Reflect Sales Loads Performance Table Market Index Changed Performance Table Uses Highest Federal Rate Performance Table Not Relevant to Tax Deferred Performance Table Explanation after Tax Higher Caption Column Label 1 Year 5 Years 10 Years Since Inception Inception Date Money Market Seven Day Yield, Caption [Text] Money Market Seven Day Yield Column [Text] Money Market Seven Day Yield Phone Money Market Seven Day Yield Money Market Seven Day Tax Equivalent Yield Thirty Day Yield Caption Thirty Day Yield Column [Text] Thirty Day Yield Phone Thirty Day Yield Thirty Day Tax Equivalent Yield Performance Table Footnotes Performance Table Closing [Text Block] Risk Section: Risk [Heading] Risk Narrative [Text Block] Risk Nondiversified Status [Text] Risk Lose Money [Text] Risk Money Market Fund [Text] Risk Not Insured Depository Institution [Text] Risk Caption Risk Column [Text] Risk [Text] Risk Footnotes [Text Block] Risk Closing [Text Block] Expense [Heading] Expense Narrative [Text Block] Expense Breakpoint Discounts [Text] Expense Exchange Traded Fund Commissions [Text] Shareholder Fees Caption [Text] Shareholder Fees Column [Text] Maximum Cumulative Sales Charge (as a percentage of Offering Price) Maximum Cumulative Sales Charge (as a percentage) Maximum sales charge imposed on purchases (as a percentage of offering price) Maximum deferred sales charge (as a percentage of the lower of original offering price or redemption proceeds) Maximum Deferred Sales Charge (as a percentage of Offering Price) Maximum Sales Charge on Reinvested Dividends and Distributions (as a percentage) Redemption Fee (as a percentage of Amount Redeemed) Redemption Fee (as a percentage of Amount Redeemed) Redemption Fee Redemption Fee Exchange Fee (as a percentage of Amount Redeemed) Exchange Fee Maximum Account Fee (as a percentage of Assets) Maximum Account Fee Shareholder Fee, Other Operating Expenses Caption [Text] Operating Expenses Column [Text] Management Fee Distribution and/or Service (12b-1) Fees Distribution or Similar (Non 12b-1) Fees Other expenses Other expenses Tax Expense Remaining Other Expenses Tax Expense Reimbursement Tax Expense Reimbursement Acquired Fund Fees and Expenses Total annual Fund operating expenses Total annual Fund operating expenses Fee waiver and/or expense reimbursement Fee waiver and/or expense reimbursement Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement Expenses Represent Both Master and Feeder [Text] Expenses Other Expenses Had Extraordinary Expenses Been Included [Text] Expenses Restated to Reflect Current [Text] Expense Example [Heading] Expense Example Narrative [Text Block] Expense Example by Year [Heading] Expense Example by, Year, Caption [Text] Expense Example, By Year, Column [Text] Column Expense Example, with Redemption, 1 Year 1 Year Expense Example, with Redemption, 3 Years 3 Years Expense Example, with Redemption, 5 Years 5 Years Expense Example, with Redemption, 10 Years 10 Years Expense Example, No Redemption, By Year, Caption [Text] Expense Example, No Redemption, By Year, Column [Text] Column Expense Example, No Redemption, 1 Year 1 Year Expense Example, No Redemption, 3 Years 3 Years Expense Example, No Redemption, 5 Years 5 Years Expense Example, No Redemption, 10 Years 10 Years Expense Example Closing [Text Block] Prospectus Date S000056147 Member (American Beacon ARK Transformational Innovation Fund℠) (American Beacon ARK Transformational Innovation Fund℠) BBBB Member American Beacon ARK Transformational Innovation Fund C000176824 Member Institutional Class C000176825 Member Investor Class C000176826 Member Class Y EX-101.PRE 6 abfunds-20181025_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 7 R1.htm IDEA: XBRL DOCUMENT

Label	Element	Value
Prospectus:	rr_ProspectusTable
Document Type	dei_DocumentType	497
Document Period End Date	dei_DocumentPeriodEndDate	Jun. 30, 2018
Registrant Name	dei_EntityRegistrantName	AMERICAN BEACON FUNDS
Central Index Key	dei_EntityCentralIndexKey	0000809593
Amendment Flag	dei_AmendmentFlag	false
Document Creation Date	dei_DocumentCreationDate	Oct. 25, 2018
Document Effective Date	dei_DocumentEffectiveDate	Oct. 25, 2018
Prospectus Date	rr_ProspectusDate	Oct. 28, 2018

XML 8 R2.htm IDEA: XBRL DOCUMENT

(American Beacon ARK Transformational Innovation Fund℠)

Investment Objective

The Fund seeks long-term growth of capital.

Fees and Expenses of the Fund

This table describes the fees and expenses that you may pay if you buy and hold shares of the Fund. More information is available from your financial professional and in "Choosing Your Share Class" on page 16 of the Prospectus.

Shareholder Fees (fees paid directly from your investment)

Shareholder Fees - (American Beacon ARK Transformational Innovation Fund℠)	Class Y	Institutional Class	Investor Class
Maximum sales charge imposed on purchases (as a percentage of offering price)	none	none	none
Maximum deferred sales charge (as a percentage of the lower of original offering price or redemption proceeds)	none	none	none

Annual Fund Operating Expenses (Expenses that you pay each year as a percentage of the value of your investment)

Annual Fund Operating Expenses - (American Beacon ARK Transformational Innovation Fund℠)		Class Y	Institutional Class	Investor Class
Management Fee		0.90%	0.90%	0.90%
Other expenses		3.94%	3.84%	4.06%
Tax Expense	^[1]	0.67%	0.67%	0.67%
Remaining Other Expenses		3.27%	3.17%	3.39%
Acquired Fund Fees and Expenses		0.01%	0.01%	0.01%
Total annual Fund operating expenses	^[2]	4.85%	4.75%	4.97%
Fee waiver and/or expense reimbursement	^[3]	(3.08%)	(3.08%)	(2.92%)
Tax Expense Reimbursement	^[4]	(0.67%)	(0.67%)	(0.67%)
Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement		1.10%	1.00%	1.38%

[1]	During the last fiscal year, the Fund invested in a wholly owned subsidiary organized under Delaware law (the "Delaware Subsidiary"). The Delaware Subsidiary's financial statements are consolidated with those of the Fund. The Delaware Subsidiary, which was liquidated on October 25, 2018, was classified for federal tax purposes as a regular corporation or so-called "C" corporation. As a "C" corporation, the Delaware Subsidiary incurred federal income tax liability associated with gains that the Delaware Subsidiary recognized on sales of its sole investment, shares of the Bitcoin Investment Trust, which the Fund had contributed to the Delaware Subsidiary. As described in Footnote 4 below, American Beacon Advisors, Inc. (the "Manager") has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust. Therefore, the reduction in the Delaware Subsidiary's value resulting from that liability did not adversely impact the Fund's net asset value per share.
[2]	The Total Annual Fund Operating Expenses do not correlate to the ratio of expenses to average net assets provided in the Fund's Financial Highlights table, which reflects the operating expenses of the Fund and does not include Acquired Fund Fees and Expenses.
[3]	American Beacon Advisors, Inc. (the "Manager") has contractually agreed to waive fees and/or reimburse expenses of the Fund's Y Class, Institutional Class and Investor Class shares through October 28, 2019 to the extent that Total Annual Fund Operating Expenses exceed 1.09% for the Y Class, 0.99% for the Institutional Class and 1.37% for the Investor Class (excluding taxes, interest, brokerage commissions, acquired fund fees and expenses, securities lending fees, expenses associated with securities sold short, litigation, and other extraordinary expenses). The contractual expense reimbursement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees. The Manager can be reimbursed by the Fund for any contractual fee waivers or expense reimbursements if reimbursement to the Manager (a) occurs within three years after the Manager's own waiver or reimbursement and (b) does not cause the Total Annual Fund Operating Expenses of a class to exceed the lesser of the contractual percentage limit in effect at the time of the waiver/reimbursement or the time of the recoupment.
[4]	The Manager has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust through October 28, 2019. The contractual agreement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees.

Example

This Example is intended to help you compare the cost of investing in the Fund with the cost of investing in other mutual funds. The Example assumes that you invest $10,000 in the Fund for the time periods indicated and then redeem all of your shares at the end of those periods. The Example also assumes that your investment has a 5% return each year and that the Fund's operating expenses remain the same, except that the Example reflects the fee waiver/expense reimbursement arrangement for each share class through October 28, 2019, and the tax liability reimbursement arrangement. Although your actual costs may be higher or lower, based on these assumptions, your costs would be:

Expense Example - (American Beacon ARK Transformational Innovation Fund℠) - USD ($)	1 Year	3 Years	5 Years	10 Years
Class Y	112	1,121	2,134	4,678
Institutional Class	102	1,092	2,088	4,598
Investor Class	141	1,171	2,202	4,782

Portfolio Turnover

The Fund pays transaction costs, such as commissions, when it buys and sells securities (or "turns over" its portfolio). A higher portfolio turnover rate may indicate higher transaction costs and may result in higher taxes when Fund shares are held in a taxable account. These costs, which are not reflected in annual Fund operating expenses or in the Example, affect the Fund's performance. During the most recent fiscal year, the Fund's portfolio turnover rate was 59% of the average value of its portfolio.

Principal Investment Strategies

The Fund seeks to achieve long-term growth of capital by investing primarily in domestic and foreign equity securities of transformational innovation companies.

The sub-advisor defines transformational innovation companies as those with divisions that primarily focus on developing or benefitting from new products, services, technologies or advancements that disrupt, or are expected to disrupt, existing markets or processes. The types of transformational innovation companies that the Fund expects to invest in are those companies primarily engaged in research, including research relating to: (i) genomics ("Genomic Revolution Research"), (ii) industrial innovation ("Industrial Innovation Research"), (iii) shared technology and the internet ("Next Generation Internet Research"), or (iv) financial services ("FinTech Innovation Research"), among others. The sub-advisor uses internally-generated and externally-sourced research and analysis to assemble a diverse array of information from which to identify transformational innovation companies.

Genomic Revolution Research. The sub-advisor defines Genomic Revolution Research as research that focuses on extending and enhancing the quality of human, and other, life. This research incorporates technological and scientific developments, improvements and advancements in genomics (the study of genes, DNA and their functions, and related analytical techniques), bionics and products or services that improve and enhance life and fundamentally change existing industries. Genomic Sequencing refers to the techniques that allow researchers to read and decipher the genetic information found in DNA. Genomic Revolution Research may be classified in multiple sectors including health care, information technology, materials, energy and consumer discretionary.
Industrial Innovation Research. The sub-advisor defines Industrial Innovation Research as research that focuses on technological improvements and advancements in the industrial sectors, including energy, manufacturing, and transportation. For example, energy transformation companies may seek to develop innovations in areas of energy location, development, storage or usage. Transportation companies may seek to develop innovation in the areas of mobility, such as drones and self-driving cars. Manufacturing innovators may seek applications for robotics, 3D printing, and similar productivity-enhancing technologies.
Next Generation Internet Research. The sub-advisor defines Next Generation Internet Research as research that focuses on developments in the global technology infrastructure, including hardware, software and the shift to mobile devices. This research may incorporate shared technology, such as shared data storage and processing, computer network applications and internet security. Applications could include, those that link homes, automobiles and workplaces to mobile devices or other convenient media.
FinTech Innovation Research. The sub-advisor defines FinTech Innovation Research as that research that focuses on innovations in the financial sector including payment technologies, lending methods, currencies and business analytics. Technology-enabled enhancements in financial services may also interact with a variety of other innovation themes as the concepts of finance apply across industries and transactions.

The sub-advisor's process for identifying investments uses both ''top down'' (macro-economic and business cycle analysis) and ''bottom up'' (valuation, fundamental and quantitative measures) approaches to identify investment opportunities.

Under normal circumstances, substantially all of the Fund's assets are invested in a portfolio of equity securities including common stocks and other equity investments or ownership interests in business enterprises that are relevant to the Fund's investment theme of transformational innovation. The Fund's investments include issuers of all capitalizations. The Fund's investments in foreign equity securities are in both developed and emerging markets. The Fund invests in American Depositary Receipts (''ADRs'') and securities sold on foreign exchanges and securities denominated in foreign currencies when purchasing foreign equities. The Fund may engage in foreign currency transactions either on a spot (cash) basis at the rate prevailing in the currency exchange market or through forward currency contracts ("forwards"). The Fund also may use foreign currency forward contracts to hedge exposure to foreign currency or to shift exposure from one currency to another. The Fund may have significant exposure to the Health Care and Information Technology sectors. However, as the sector composition of the Fund's portfolio changes over time, the Fund's exposure to these sectors may be lower at a future date, and the Fund's exposure to other market sectors may be higher.

The sub-advisor may sell a security if it believes that a company has become disrupted or is no longer on the leading edge of fast-moving industries or innovation. The sub-advisor may also sell positions to (i) take advantage of opportunities created by short-term market actions or market sentiment, (ii) provide liquidity to invest in companies that the sub-advisor has relatively more confidence in, or (iii) invest in companies that the sub-advisor believes offer more market opportunity relative to their current price. The Fund at times may invest in shares of other investment companies, including money market funds and exchange-traded funds ("ETFs"), and may lend its securities to broker-dealers and other institutions to earn additional income. The Fund may invest in securities of investment companies advised by the Manager.

In pursuing its investment strategies, the Fund typically engages in active trading strategies that result in high portfolio turnover.

The Fund is non-diversified, which means that it may invest a high percentage of its assets in a limited number of issuers.

The Fund is the sole shareholder of a wholly owned subsidiary that is organized under the laws of the Cayman Islands (the "Subsidiary"). The Subsidiary was established to enable the Fund to seek exposure to certain investments that may not produce qualifying income for the Fund under the Internal Revenue Code of 1986, as amended. The Subsidary has not engaged in any investment activity and is not expected to do so in the future. The Subsidiary is anticipated to terminate in the near future.

Principal Risks

There is no assurance that the Fund will achieve its investment objective and you could lose part or all of your investment in the Fund. The Fund is not designed for investors who need an assured level of income and is intended to be a long-term investment. The Fund is not a complete investment program and may not be appropriate for all investors. Investors should carefully consider their own investment goals and risk tolerance before investing in the Fund. The principal risks of investing in the Fund are:

Allocation and Correlation Risk
The sub-advisor's judgments about, and allocations among asset classes and market exposures may adversely affect the Fund's performance. There can be no assurance, particularly during periods of market disruption and stress, that the sub-advisor's judgements about asset allocation and market correlations will be correct.

Asset Selection Risk
Assets selected by the sub-advisor or the Manager for the Fund may not perform to expectations. The sub-advisor's investment models may rely in part on data derived from third parties and may not perform as intended. This could result in the Fund's underperformance compared to other funds with similar investment objectives.

Currency Risk
The Fund may have exposure to foreign currencies by making direct investments in non-U.S. currencies, investing in securities denominated in non-U.S. currencies or by purchasing or selling forward currency exchange contracts in non-U.S. currencies. Foreign currencies will fluctuate, and may decline in value relative to the U.S. dollar and other currencies and thereby affect the Fund's investments in foreign (non-U.S.) currencies or in securities that trade in, and receive revenues in, or in derivatives that provide exposure to, foreign (non-U.S.) currencies.

Cybersecurity and Operational Risk
The Fund and its service providers, and shareholders' ability to transact with the Fund, may be negatively impacted due to operational risks arising from, among other problems, human errors, systems and technology disruptions or failures, or cybersecurity incidents. Cybersecurity incidents may allow an unauthorized party to gain access to Fund assets, customer data, or proprietary information, or cause the Fund or its service providers, as well as the securities trading venues and their service providers, to suffer data corruption or lose operational functionality. It is not possible for the Fund or its service providers to identify all of the operational risks that may affect the Fund or to develop processes and controls to completely eliminate or mitigate their occurrence or effects. Most issuers in which the Fund invests are heavily dependent on computers for data storage and operations, and require ready access to the internet to conduct their business. Thus, cybersecurity incidents could also affect issuers of securities in which the Fund invests, leading to significant loss of value.

Derivatives Risk
Derivatives may involve significant risk. The use of derivative instruments may expose the Fund to additional risks that it would not be subject to if it invested directly in the securities or other instruments underlying those derivatives, including the high degree of leverage often embedded in such instruments, and potential material and prolonged deviations between the theoretical value and realizable value of a derivative. Some derivatives have the potential for unlimited loss, regardless of the size of the Fund's initial investment. Derivatives may be illiquid and may be more volatile than other types of investments. The Fund may buy or sell derivatives not traded on an exchange and which may be subject to heightened liquidity and valuation risk. Derivative investments can increase portfolio turnover and transaction costs. Derivatives also are subject to counterparty risk and credit risk. As a result, the Fund may obtain no recovery of its investment or may only obtain a limited recovery, and any recovery may be delayed. Not all derivative transactions require a counterparty to post collateral, which may expose the Fund to greater losses in the event of a default by a counterparty. Ongoing changes to regulation of the derivatives market and potential changes in the regulation of funds using derivative instruments could limit the Fund's ability to pursue its investment strategies.In addition, the Fund's investments in derivatives are subject to the following risks:

Forward Contracts. Forward contracts are derivative instruments pursuant to a contract where one party pays a fixed price for an agreed amount of securities or other underlying assets at an agreed date or to buy or sell a specific currency at a future date at a price set at the time of the contract. There can be no assurance that any strategy used will succeed. Not all forward contracts require a counterparty to post collateral, which may expose the Fund to greater losses in the event of a default by a counterparty. Forward currency transactions and forward currency contracts include the risks associated with fluctuations in currency.

Emerging Markets Risk
When investing in emerging markets, the risks of investing in foreign securities discussed below are heightened. Emerging markets are generally smaller, less developed, less liquid and more volatile than the securities markets of the U.S. and other developed markets. There are also risks of: greater political uncertainties; an economy's dependence on revenues from particular commodities or on international aid or development assistance; currency transfer restrictions; a limited number of potential buyers for such securities resulting in increased volatility and limited liquidity for emerging market securities; trading suspensions; and delays and disruptions in securities settlement procedures.

Equity Investments Risk
Equity securities are subject to investment risk and market risk. The Fund's investments in U.S. and foreign equity securities may include common stocks and depositary receipts. Such investments may expose the Fund to additional risks.

Common Stock. The value of a company's common stock may fall as a result of factors affecting the company, companies in the same industry or sector, or the financial markets overall. Common stock generally is subordinate to preferred stock upon the liquidation or bankruptcy of the issuing company.
Depositary Receipts. Depositary receipts and U.S. dollar-denominated foreign stocks traded on U.S. exchanges are subject to certain of the risks associated with investing directly in foreign securities including, but not limited to, currency exchange rate fluctuations, political and financial instability in the home country of a particular depositary receipt or foreign stock, less liquidity and more volatility, less government regulation and supervision and delays in transaction settlement.

Foreign Investing Risk
Non-U.S. investments carry potential risks not associated with U.S. investments. Such risks include, but are not limited to: (1) currency exchange rate fluctuations, (2) political and financial instability, (3) less liquidity, (4) lack of uniform accounting, auditing and financial reporting standards, (5) increased volatility, (6) different government regulation and supervision of foreign stock exchanges, brokers and listed companies, and (7) delays in transaction settlement in some foreign markets.

Hedging Risk
If the Fund uses a hedging instrument at the wrong time or judges the market conditions incorrectly, or the hedged instrument does not correlate to the risk sought to be hedged, the hedge might be unsuccessful, reduce the Fund's return, or create a loss. In addition, hedges, even when successful in mitigating risk, may not prevent the Fund from experiencing losses on its investments, and therefore the use of hedging strategies may reduce the Fund's return, or create a loss.

Investment Risk
An investment in the Fund is not a deposit with a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency. When you sell your shares of the Fund, they could be worth less than what you paid for them. Therefore, you may lose money by investing in the Fund.

Issuer Risk
The value of, and/or the return generated by, a security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage and reduced demand for the issuer's goods or services, as well as the historical and prospective earnings of the issuer and the value of its assets.

Large Capitalization Companies Risk
The securities of large market capitalization companies may underperform other segments of the market because such companies may be less responsive to competitive challenges and opportunities and may be unable to attain the high growth rates of successful smaller companies, especially during periods of economic expansion.

Liquidity Risk
The Fund is susceptible to the risk that certain investments held by the Fund, such as forward contracts, may have limited marketability or be subject to restrictions on sale, and may be difficult or impossible to purchase or sell at favorable times or prices. The Fund could lose money if it is unable to dispose of an investment at a time that is most beneficial to the Fund. The Fund may be required to dispose of investments at unfavorable times or prices to satisfy obligations, which may result in losses or may be costly to the Fund. For example, the Fund may be forced to sell certain investments at unfavorable prices to meet redemption requests or other cash needs. Judgment plays a greater role in pricing illiquid investments than in investments with more active markets.

Market Risk
Since the financial crisis that started in 2008, the U.S. and many foreign economies continue to experience its after-effects, which have resulted, and may continue to result, in fixed income instruments experiencing unusual liquidity issues, increased price volatility and, in some cases, credit downgrades and increased likelihood of default. These events have reduced the willingness and ability of some lenders to extend credit, and have made it more difficult for some borrowers to obtain financing on attractive terms, if at all. In addition, global economies and financial markets are becoming increasingly interconnected, which increases the possibilities that conditions in one country or region might adversely impact issuers in a different country or region. A rise in protectionist trade policies, and the possibility of changes to some international trade agreements, could affect the economies of many nations in ways that cannot necessarily be foreseen at the present time. The severity or duration of adverse economic conditions may also be affected by policy changes made by governments or quasi-governmental organizations.

In addition, political events within the U.S. and abroad may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. High public debt in the U.S. and other countries creates ongoing systemic and market risks and policymaking uncertainty. Because the impact on the markets has been widespread, it may be difficult to identify both risks and opportunities using past models of the interplay of market forces, or to predict the duration of these market conditions. Interest rates have been unusually low in recent years in the U.S. and abroad. Because there is little precedent for this situation, it is difficult to predict the impact on various markets of a significant rate increase, whether brought about by U.S. policy makers or by dislocations in world markets. In addition, there is a risk that the prices of goods and services in the U.S. and many foreign economies may decline over time, known as deflation (the opposite of inflation). Deflation may have an adverse effect on stock prices and creditworthiness and may make defaults on debt more likely.

Market Timing Risk
Because the Fund invests in foreign securities, or it has exposure to foreign securities through the derivatives it holds, it is particularly subject to the risk of market timing activities. Frequent trading by Fund shareholders poses risks to other shareholders in the Fund, including (i) the dilution of the Fund's net asset value ("NAV"), (ii) an increase in the Fund's expenses, and (iii) interference with the portfolio manager's ability to execute efficient investment strategies. Because of specific types of securities in which the Fund may invest, it could be subject to the risk of market timing activities by shareholders.

Micro-Capitalization Companies Risk
Micro-capitalization companies are subject to substantially greater risks of loss and price fluctuations because their earnings and revenues tend to be less predictable, since micro-capitalization companies may not have operating history, product lines, and financial resources. Their share prices tend to be more volatile and their markets less liquid than companies with larger market capitalizations, and they can be sensitive to expected changes in interest rates, borrowing costs and earnings. The shares of micro-capitalization companies tend to trade less frequently than those of larger, more established companies, which can adversely affect the pricing of these securities and the future ability to sell these securities.

Model Risk
The sub-advisor may use proprietary modeling systems to implement its investment strategies for the Fund. Investments selected using these models may perform differently than expected as a result of the factors used in the models, the weight placed on each factor, changes from the factors' historical trends and technical issues in the construction and implementation of the models. There is no assurance that the models are complete or accurate, or representative of future market cycles, nor will they necessarily be beneficial to the Fund if they are accurate. These models may negatively affect Fund performance for various reasons, including human judgment, inaccuracy of historical data and non-quantitative factors (such as market or trading system dysfunctions, investor fear or over-reaction).

Non-Diversification Risk
The Fund is non-diversified, which means it may focus its investments in the securities of a comparatively small number of issuers. Investments in securities of a limited number of issuers exposes the Fund to greater market risk and potential losses than if assets were diversified among the securities of a greater number of issuers.

Other Investment Companies Risk
The Fund may invest in shares of other registered investment companies, including money market funds and exchange-traded funds ("ETFs"). To the extent that the Fund invests in shares of other registered investment companies, the Fund will indirectly bear the fees and expenses charged by those investment companies in addition to the Fund's direct fees and expenses and will be subject to the risks associated with investments in those companies. For example, money market funds are subject to interest rate risk, credit risk, and market risk. To the extent the Fund invests in ETFs that invest in equity securities, fixed income securities and/or foreign securities, or that track an index, the Fund would be subject to the risks associated with the underlying investments held by the ETF or the index fluctuations to which the ETF is subject. Because ETFs are listed on an exchange, they may be subject to trading halts, may trade at a discount or premium to their NAV and may not be liquid. ETF shares may trade at a premium or discount to their NAV. An ETF that tracks an index may not precisely replicate the returns of its benchmark index.

Sector Risk
To the extent the Fund invests more heavily in particular sectors, its performance will be especially sensitive to developments and economic conditions that significantly affect those sectors. Individual sectors may move up and down more than the broader market. The industries that constitute a sector may all react in the same way to economic, political or regulatory events. Because the Fund may hold a limited number of securities, it may at times be substantially over-weighted in certain economic sectors and under-weighted in others. Accordingly, the Fund's performance is likely to be disproportionately affected by the factors influencing those sectors.

Health Care Sector Risk. The health care sector may be affected by government regulations and health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Many health care companies are (i) heavily dependent on patent protection and intellectual property rights and the expiration of a patent may adversely affect their profitability, (ii) subject to extensive litigation based on product liability and similar claims, and (iii) subject to competitive forces that may make it difficult to raise prices and, may result in price discounting. Many health care products and services may be subject to regulatory approvals. The process of obtaining such approvals may be long and costly, and delays in or failure to receive such approvals may negatively impact the business of such companies. Additional or more stringent laws and regulations enacted in the future could have a material adverse effect on companies in the health care sector. In addition, issuers in the health care sector include issuers having their principal activities in the biotechnology and pharmaceutical industries, which have the additional risks described below.

Biotechnology Company Risk. A biotechnology company's valuation can often be based largely on the potential or actual performance of a limited number of products and can accordingly be greatly affected if one of its products proves unsafe, ineffective or unprofitable.
Pharmaceutical Company Risk. Companies in the pharmaceutical industry can be significantly affected by government approval of products and services, government regulation and reimbursement rates, product liability claims, patent expirations and intense competition.

Information Technology Sector Risk. The information technology sector includes companies engaged in internet software and services, technology hardware and storage peripherals, electronic equipment and components, and semiconductors and semiconductor equipment. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Information technology companies may have limited product lines, markets, financial resources or personnel. The products of information technology companies may face rapid product obsolescence due to technological developments and frequent new product introduction, unpredictable changes in growth rates and competition for the services of qualified personnel. Failure to introduce new products, develop and maintain a loyal customer base or achieve general market acceptance for their products could have a material adverse effect on a company's business. Companies in the information technology sector are heavily dependent on intellectual property and the loss of patent, copyright and trademark protections may adversely affect the profitability of these companies.

Financial Technology Company Risk. FinTech companies generally face competition from much larger and more established firms. FinTech companies may not be able to capitalize on their disruptive technologies if they face political and/or legal attacks from competitors, industry groups or local and national governments. A FinTech company may not currently or in the future derive any revenue from innovative technologies.

Securities Lending Risk
To the extent the Fund lends its securities, it may be subject to the following risks: i) borrowers of the Fund's securities typically provide collateral in the form of cash that is reinvested in securities, ii) the securities in which the collateral is invested may not perform sufficiently to cover the return collateral payments owed to borrowers, iii) delays may occur in the recovery of securities from borrowers, which could interfere with the Fund's ability to vote proxies or to settle transactions, and iv) there is the risk of possible loss of rights in the collateral should the borrower fail financially.

Small and Mid-Capitalization Companies Risk
Investing in the securities of small and mid-capitalization companies involves greater risk and the possibility of greater price volatility than investing in larger capitalization and more established companies. Since small and mid-capitalization companies may have narrower commercial markets and more limited operating history, product lines, and managerial and financial resources than larger, more established companies, the securities of these companies may lack sufficient market liquidity, and they can be particularly sensitive to expected changes in interest rates, borrowing costs and earnings. In general, these risks are greater for small-capitalization companies than for mid-capitalization companies.

Transformational Innovation Risk
Companies that the sub-advisor believes are capitalizing on transformational innovation and developing technologies to displace older technologies or create new markets may not in fact do so. Companies that initially develop a novel technology may not be able to capitalize on the technology. Companies that develop transformational technologies may face political or legal challenges from competitors, industry groups or local and national governments. These companies may also be exposed to risks applicable to sectors other than the transformational innovation theme for which they are chosen, and the securities issued by these companies may underperform the securities of other companies that are also focused on a particular theme.

Valuation Risk
The Fund may value certain assets at a price different from the price at which they can be sold. This risk may be especially pronounced for investments that are illiquid or which may become illiquid.

Fund Performance

Performance information for the Fund is not provided because the Fund had not been in operation for a full calendar year as of the date of this Prospectus. Performance for the Fund can be accessed on the Fund's website at www.americanbeaconfunds.com. Past performance (before and after taxes) is not necessarily an indication of how the Fund will perform in the future.

XML 9 R6.htm IDEA: XBRL DOCUMENT

Label

Element

Value

(American Beacon ARK Transformational Innovation Fund℠)

Prospectus:

rr_ProspectusTable

Objective [Heading]

rr_ObjectiveHeading

Investment Objective

Objective, Primary [Text Block]

rr_ObjectivePrimaryTextBlock

The Fund seeks long-term growth of capital.

Expense [Heading]

rr_ExpenseHeading

Fees and Expenses of the Fund

Expense Narrative [Text Block]

rr_ExpenseNarrativeTextBlock

Shareholder Fees Caption [Text]

rr_ShareholderFeesCaption

Shareholder Fees (fees paid directly from your investment)

Operating Expenses Caption [Text]

rr_OperatingExpensesCaption

Fee Waiver or Reimbursement over Assets, Date of Termination

rr_FeeWaiverOrReimbursementOverAssetsDateOfTermination

October 28, 2019

Expenses Not Correlated to Ratio Due to Acquired Fund Fees [Text]

rr_ExpensesNotCorrelatedToRatioDueToAcquiredFundFees

The Total Annual Fund Operating Expenses do not correlate to the ratio of expenses to average net assets provided in the Fund's Financial Highlights table, which reflects the operating expenses of the Fund and does not include Acquired Fund Fees and Expenses.

Expense Example [Heading]

rr_ExpenseExampleHeading

Example

Expense Example Narrative [Text Block]

rr_ExpenseExampleNarrativeTextBlock

Portfolio Turnover [Heading]

rr_PortfolioTurnoverHeading

Portfolio Turnover

Portfolio Turnover [Text Block]

rr_PortfolioTurnoverTextBlock

Portfolio Turnover, Rate

rr_PortfolioTurnoverRate

59.00%

Strategy [Heading]

rr_StrategyHeading

Principal Investment Strategies

Strategy Narrative [Text Block]

rr_StrategyNarrativeTextBlock

The Fund seeks to achieve long-term growth of capital by investing primarily in domestic and foreign equity securities of transformational innovation companies.

Genomic Revolution Research. The sub-advisor defines Genomic Revolution Research as research that focuses on extending and enhancing the quality of human, and other, life. This research incorporates technological and scientific developments, improvements and advancements in genomics (the study of genes, DNA and their functions, and related analytical techniques), bionics and products or services that improve and enhance life and fundamentally change existing industries. Genomic Sequencing refers to the techniques that allow researchers to read and decipher the genetic information found in DNA. Genomic Revolution Research may be classified in multiple sectors including health care, information technology, materials, energy and consumer discretionary.
Industrial Innovation Research. The sub-advisor defines Industrial Innovation Research as research that focuses on technological improvements and advancements in the industrial sectors, including energy, manufacturing, and transportation. For example, energy transformation companies may seek to develop innovations in areas of energy location, development, storage or usage. Transportation companies may seek to develop innovation in the areas of mobility, such as drones and self-driving cars. Manufacturing innovators may seek applications for robotics, 3D printing, and similar productivity-enhancing technologies.
Next Generation Internet Research. The sub-advisor defines Next Generation Internet Research as research that focuses on developments in the global technology infrastructure, including hardware, software and the shift to mobile devices. This research may incorporate shared technology, such as shared data storage and processing, computer network applications and internet security. Applications could include, those that link homes, automobiles and workplaces to mobile devices or other convenient media.
FinTech Innovation Research. The sub-advisor defines FinTech Innovation Research as that research that focuses on innovations in the financial sector including payment technologies, lending methods, currencies and business analytics. Technology-enabled enhancements in financial services may also interact with a variety of other innovation themes as the concepts of finance apply across industries and transactions.

In pursuing its investment strategies, the Fund typically engages in active trading strategies that result in high portfolio turnover.

The Fund is non-diversified, which means that it may invest a high percentage of its assets in a limited number of issuers.

Risk [Heading]

rr_RiskHeading

Principal Risks

Risk Narrative [Text Block]

rr_RiskNarrativeTextBlock

Forward Contracts. Forward contracts are derivative instruments pursuant to a contract where one party pays a fixed price for an agreed amount of securities or other underlying assets at an agreed date or to buy or sell a specific currency at a future date at a price set at the time of the contract. There can be no assurance that any strategy used will succeed. Not all forward contracts require a counterparty to post collateral, which may expose the Fund to greater losses in the event of a default by a counterparty. Forward currency transactions and forward currency contracts include the risks associated with fluctuations in currency.

Common Stock. The value of a company's common stock may fall as a result of factors affecting the company, companies in the same industry or sector, or the financial markets overall. Common stock generally is subordinate to preferred stock upon the liquidation or bankruptcy of the issuing company.
Depositary Receipts. Depositary receipts and U.S. dollar-denominated foreign stocks traded on U.S. exchanges are subject to certain of the risks associated with investing directly in foreign securities including, but not limited to, currency exchange rate fluctuations, political and financial instability in the home country of a particular depositary receipt or foreign stock, less liquidity and more volatility, less government regulation and supervision and delays in transaction settlement.

Health Care Sector Risk. The health care sector may be affected by government regulations and health care programs, restrictions on government reimbursement for medical expenses, increases or decreases in the cost of medical products and services and product liability claims, among other factors. Many health care companies are (i) heavily dependent on patent protection and intellectual property rights and the expiration of a patent may adversely affect their profitability, (ii) subject to extensive litigation based on product liability and similar claims, and (iii) subject to competitive forces that may make it difficult to raise prices and, may result in price discounting. Many health care products and services may be subject to regulatory approvals. The process of obtaining such approvals may be long and costly, and delays in or failure to receive such approvals may negatively impact the business of such companies. Additional or more stringent laws and regulations enacted in the future could have a material adverse effect on companies in the health care sector. In addition, issuers in the health care sector include issuers having their principal activities in the biotechnology and pharmaceutical industries, which have the additional risks described below.

Biotechnology Company Risk. A biotechnology company's valuation can often be based largely on the potential or actual performance of a limited number of products and can accordingly be greatly affected if one of its products proves unsafe, ineffective or unprofitable.
Pharmaceutical Company Risk. Companies in the pharmaceutical industry can be significantly affected by government approval of products and services, government regulation and reimbursement rates, product liability claims, patent expirations and intense competition.

Information Technology Sector Risk. The information technology sector includes companies engaged in internet software and services, technology hardware and storage peripherals, electronic equipment and components, and semiconductors and semiconductor equipment. Information technology companies face intense competition, both domestically and internationally, which may have an adverse effect on profit margins. Information technology companies may have limited product lines, markets, financial resources or personnel. The products of information technology companies may face rapid product obsolescence due to technological developments and frequent new product introduction, unpredictable changes in growth rates and competition for the services of qualified personnel. Failure to introduce new products, develop and maintain a loyal customer base or achieve general market acceptance for their products could have a material adverse effect on a company's business. Companies in the information technology sector are heavily dependent on intellectual property and the loss of patent, copyright and trademark protections may adversely affect the profitability of these companies.

Financial Technology Company Risk. FinTech companies generally face competition from much larger and more established firms. FinTech companies may not be able to capitalize on their disruptive technologies if they face political and/or legal attacks from competitors, industry groups or local and national governments. A FinTech company may not currently or in the future derive any revenue from innovative technologies.

Risk Nondiversified Status [Text]

rr_RiskNondiversifiedStatus

Non-Diversification Risk The Fund is non-diversified, which means it may focus its investments in the securities of a comparatively small number of issuers. Investments in securities of a limited number of issuers exposes the Fund to greater market risk and potential losses than if assets were diversified among the securities of a greater number of issuers.

Risk Lose Money [Text]

rr_RiskLoseMoney

There is no assurance that the Fund will achieve its investment objective and you could lose part or all of your investment in the Fund.

Risk Not Insured Depository Institution [Text]

rr_RiskNotInsuredDepositoryInstitution

An investment in the Fund is not a deposit with a bank and is not insured or guaranteed by the Federal Deposit Insurance Corporation or any other government agency.

Bar Chart and Performance Table [Heading]

rr_BarChartAndPerformanceTableHeading

Fund Performance

Performance Narrative [Text Block]

rr_PerformanceNarrativeTextBlock

Performance Past Does Not Indicate Future [Text]

rr_PerformancePastDoesNotIndicateFuture

Past performance (before and after taxes) is not necessarily an indication of how the Fund will perform in the future.

Performance Availability Website Address [Text]

rr_PerformanceAvailabilityWebSiteAddress

www.americanbeaconfunds.com

(American Beacon ARK Transformational Innovation Fund℠) | Class Y

Prospectus:

rr_ProspectusTable

Maximum sales charge imposed on purchases (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum deferred sales charge (as a percentage of the lower of original offering price or redemption proceeds)

rr_MaximumDeferredSalesChargeOverOther

none

Management Fee

rr_ManagementFeesOverAssets

0.90%

Other expenses

rr_OtherExpensesOverAssets

3.94%

Tax Expense

rr_Component1OtherExpensesOverAssets

0.67%

^[1]

Remaining Other Expenses

rr_Component2OtherExpensesOverAssets

3.27%

Acquired Fund Fees and Expenses

rr_AcquiredFundFeesAndExpensesOverAssets

0.01%

Total annual Fund operating expenses

rr_ExpensesOverAssets

4.85%

^[2]

Fee waiver and/or expense reimbursement

rr_FeeWaiverOrReimbursementOverAssets

(3.08%)

^[3]

Tax Expense Reimbursement

rr_Component3OtherExpensesOverAssets

(0.67%)

^[4]

Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement

rr_NetExpensesOverAssets

1.10%

Expense Example, with Redemption, 1 Year

rr_ExpenseExampleYear01

$ 112

Expense Example, with Redemption, 3 Years

rr_ExpenseExampleYear03

1,121

Expense Example, with Redemption, 5 Years

rr_ExpenseExampleYear05

2,134

Expense Example, with Redemption, 10 Years

rr_ExpenseExampleYear10

$ 4,678

(American Beacon ARK Transformational Innovation Fund℠) | Institutional Class

Prospectus:

rr_ProspectusTable

Maximum sales charge imposed on purchases (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum deferred sales charge (as a percentage of the lower of original offering price or redemption proceeds)

rr_MaximumDeferredSalesChargeOverOther

none

Management Fee

rr_ManagementFeesOverAssets

0.90%

Other expenses

rr_OtherExpensesOverAssets

3.84%

Tax Expense

rr_Component1OtherExpensesOverAssets

0.67%

^[1]

Remaining Other Expenses

rr_Component2OtherExpensesOverAssets

3.17%

Acquired Fund Fees and Expenses

rr_AcquiredFundFeesAndExpensesOverAssets

0.01%

Total annual Fund operating expenses

rr_ExpensesOverAssets

4.75%

^[2]

Fee waiver and/or expense reimbursement

rr_FeeWaiverOrReimbursementOverAssets

(3.08%)

^[3]

Tax Expense Reimbursement

rr_Component3OtherExpensesOverAssets

(0.67%)

^[4]

Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement

rr_NetExpensesOverAssets

1.00%

Expense Example, with Redemption, 1 Year

rr_ExpenseExampleYear01

$ 102

Expense Example, with Redemption, 3 Years

rr_ExpenseExampleYear03

1,092

Expense Example, with Redemption, 5 Years

rr_ExpenseExampleYear05

2,088

Expense Example, with Redemption, 10 Years

rr_ExpenseExampleYear10

$ 4,598

(American Beacon ARK Transformational Innovation Fund℠) | Investor Class

Prospectus:

rr_ProspectusTable

Maximum sales charge imposed on purchases (as a percentage of offering price)

rr_MaximumSalesChargeImposedOnPurchasesOverOfferingPrice

none

Maximum deferred sales charge (as a percentage of the lower of original offering price or redemption proceeds)

rr_MaximumDeferredSalesChargeOverOther

none

Management Fee

rr_ManagementFeesOverAssets

0.90%

Other expenses

rr_OtherExpensesOverAssets

4.06%

Tax Expense

rr_Component1OtherExpensesOverAssets

0.67%

^[1]

Remaining Other Expenses

rr_Component2OtherExpensesOverAssets

3.39%

Acquired Fund Fees and Expenses

rr_AcquiredFundFeesAndExpensesOverAssets

0.01%

Total annual Fund operating expenses

rr_ExpensesOverAssets

4.97%

^[2]

Fee waiver and/or expense reimbursement

rr_FeeWaiverOrReimbursementOverAssets

(2.92%)

^[3]

Tax Expense Reimbursement

rr_Component3OtherExpensesOverAssets

(0.67%)

^[4]

Total Annual Fund Operating Expenses after fee waiver and/or expense reimbursement

rr_NetExpensesOverAssets

1.38%

Expense Example, with Redemption, 1 Year

rr_ExpenseExampleYear01

$ 141

Expense Example, with Redemption, 3 Years

rr_ExpenseExampleYear03

1,171

Expense Example, with Redemption, 5 Years

rr_ExpenseExampleYear05

2,202

Expense Example, with Redemption, 10 Years

rr_ExpenseExampleYear10

$ 4,782

[1]	During the last fiscal year, the Fund invested in a wholly owned subsidiary organized under Delaware law (the "Delaware Subsidiary"). The Delaware Subsidiary's financial statements are consolidated with those of the Fund. The Delaware Subsidiary, which was liquidated on October 25, 2018, was classified for federal tax purposes as a regular corporation or so-called "C" corporation. As a "C" corporation, the Delaware Subsidiary incurred federal income tax liability associated with gains that the Delaware Subsidiary recognized on sales of its sole investment, shares of the Bitcoin Investment Trust, which the Fund had contributed to the Delaware Subsidiary. As described in Footnote 4 below, American Beacon Advisors, Inc. (the "Manager") has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust. Therefore, the reduction in the Delaware Subsidiary's value resulting from that liability did not adversely impact the Fund's net asset value per share.
[2]	The Total Annual Fund Operating Expenses do not correlate to the ratio of expenses to average net assets provided in the Fund's Financial Highlights table, which reflects the operating expenses of the Fund and does not include Acquired Fund Fees and Expenses.
[3]	American Beacon Advisors, Inc. (the "Manager") has contractually agreed to waive fees and/or reimburse expenses of the Fund's Y Class, Institutional Class and Investor Class shares through October 28, 2019 to the extent that Total Annual Fund Operating Expenses exceed 1.09% for the Y Class, 0.99% for the Institutional Class and 1.37% for the Investor Class (excluding taxes, interest, brokerage commissions, acquired fund fees and expenses, securities lending fees, expenses associated with securities sold short, litigation, and other extraordinary expenses). The contractual expense reimbursement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees. The Manager can be reimbursed by the Fund for any contractual fee waivers or expense reimbursements if reimbursement to the Manager (a) occurs within three years after the Manager's own waiver or reimbursement and (b) does not cause the Total Annual Fund Operating Expenses of a class to exceed the lesser of the contractual percentage limit in effect at the time of the waiver/reimbursement or the time of the recoupment.
[4]	The Manager has contractually agreed to reimburse the Fund for the amount of any tax liability incurred by the Delaware Subsidiary in connection with the sale of its shares of the Bitcoin Investment Trust through October 28, 2019. The contractual agreement can be changed or terminated only in the discretion and with the approval of a majority of the Fund's Board of Trustees.

XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 5 50 1 true 4 0 false 4 false false R1.htm 010001 - Document - Document And Entity Information {Elements} Sheet http://abfunds-20181025/role/DocumentDocumentandEntityInformation Document And Entity Information 1 false true R2.htm 010003 - Document - American Beacon ARK Transformational Innovation Fund {Unlabeled} Sheet http://abfunds-20181025/role/BBBB American Beacon ARK Transformational Innovation Fund 2 false false R6.htm 040000 - Disclosure - Risk/Return Detail Data {Elements} Sheet http://xbrl.sec.gov/rr/role/RiskReturnDetailData Risk/Return Detail Data 3 false false All Reports Book All Reports abfunds-20181025.xml abfunds-20181025.xsd abfunds-20181025_def.xml abfunds-20181025_lab.xml abfunds-20181025_pre.xml http://xbrl.sec.gov/rr/2012-01-31 http://xbrl.sec.gov/dei/2012-01-31 true false ZIP 15 0001133228-18-006113-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001133228-18-006113-xbrl.zip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end